Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer

The combination of Aidi injection (ADI) and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in treating non-small cell lung cancer (NSCLC) has been reported, but the effects of this therapy have not been systematically assessed. Randomized controlled trials (RCTs) published bef...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Na, He, Hailang, Wang, Jing, Zhang, Li, Chow, Brandon, Feng, Fanchao, Xu, Yong, Huang, Jingyi, Zhou, Xianmei, Dong, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Topical Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114743/
https://www.ncbi.nlm.nih.gov/pubmed/33926244
http://dx.doi.org/10.1177/2515690X211010733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114743/
https://www.ncbi.nlm.nih.gov/pubmed/33926244
http://dx.doi.org/10.1177/2515690X211010733

Ejemplares similares